Search Results - "Perez‐Oteyza, Jaime"

A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia by Onecha, Esther, Linares, Maria, Rapado, Inmaculada, Ruiz-Heredia, Yanira, Martinez-Sanchez, Pilar, Cedena, Teresa, Pratcorona, Marta, Oteyza, Jaime Perez, Herrera, Pilar, Barragan, Eva, Montesinos, Pau, Vela, Jose Antonio Garcia, Magro, Elena, Anguita, Eduardo, Figuera, Angela, Riaza, Rosalia, Martinez-Barranco, Pilar, Sanchez-Vega, Beatriz, Nomdedeu, Josep, Gallardo, Miguel, Martinez-Lopez, Joaquin, Ayala, Rosa

“…A high proportion of patients with acute myeloid leukemia who achieve minimal residual disease negative status ultimately relapse because a fraction of…”
Get full text

Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity by Onecha, Esther, Ruiz‐Heredia, Yanira, Martínez‐Cuadrón, David, Barragán, Eva, Martinez‐Sanchez, Pilar, Linares, María, Rapado, Inmaculada, Perez‐Oteyza, Jaime, Magro, Elena, Herrera, Pilar, Rojas, José Luis, Gorrochategui, Julián, Villoria, Jesús, Boluda, Blanca, Sargas, Claudia, Ballesteros, Joan, Montesinos, Pau, Martínez‐López, Joaquín, Ayala, Rosa

“…Summary Refractoriness to induction therapy and relapse after complete remission are the leading causes of death in patients with acute myeloid leukaemia…”
Get full text

Azacitidine improves outcome in higher‐risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries by Díez‐Campelo, María, Lorenzo, Jose I., Itzykson, Raphael, Rojas, Silvia M., Berthon, Céline, Luño, Elisa, Beyne‐Rauzy, Odile, Perez‐Oteyza, Jaime, Vey, Norbert, Bargay, Joan, Park, Sophie, Cedena, Teresa, Bordessoule, Dominique, Muñoz, Juan A., Gyan, Emmanuel, Such, Esperanza, Visanica, Sorin, López‐Cadenas, Félix, Botton, Stéphane, Hernández‐Rivas, Jesús M., Ame, Shanti, Stamatoullas, Aspasia, Delaunay, Jacques, Salanoubat, Celia, Isnard, Françoise, Guieze, Romain, Pérez Guallar, Joan, Badiella, Llorenc, Sanz, Guillermo, Cañizo, Consuelo, Fenaux, Pierre

“…Summary Treatment with azacitidine (AZA) has been suggested to be of benefit for higher‐risk myelodysplastic syndrome (HR‐MDS) patients with chromosome 7…”
Get full text

Efficacy and Safety of Linezolid Compared with Vancomycin in a Randomized, Double-Blind Study of Febrile Neutropenic Patients with Cancer by Jaksic, Branimir, Martinelli, Giovanni, Oteyza, Jaime Perez, Hartman, Charlotte S., Leonard, Linda B., Tack, Kenneth J.

“…Background. Gram-positive pathogens can cause serious infections in neutropenic patients with cancer, and vancomycin therapy is often initiated empirically…”
Get full text

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms by Steensma, David P., Wermke, Martin, Klimek, Virginia M., Greenberg, Peter L., Font, Patricia, Komrokji, Rami S., Yang, Jay, Brunner, Andrew M., Carraway, Hetty E., Ades, Lionel, Al-Kali, Aref, Alonso-Dominguez, Juan M., Alfonso-Piérola, Ana, Coombs, Catherine C., Deeg, H. Joachim, Flinn, Ian, Foran, James M., Garcia-Manero, Guillermo, Maris, Michael B., McMasters, Malgorzata, Micol, Jean-Baptiste, De Oteyza, Jaime Perez, Thol, Felicitas, Wang, Eunice S., Watts, Justin M., Taylor, Justin, Stone, Richard, Gourineni, Vikram, Marino, Alyssa J., Yao, Huilan, Destenaves, Benoit, Yuan, Xiaobin, Yu, Kun, Dar, Sara, Ohanjanian, Lernik, Kuida, Keisuke, Xiao, Jianjun, Scholz, Catherine, Gualberto, Antonio, Platzbecker, Uwe

“…We conducted a phase I clinical trial of H3B-8800, an oral small molecule that binds Splicing Factor 3B1 (SF3B1), in patients with MDS, CMML, or AML. Among 84…”
Get full text

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial by RIBERA, Josep-Maria, ORIOL, Albert, MARTIN-REINA, Victoria, SARRA, Josep, PARODY, Ricardo, PEREZ DE OTEYZA, Jaime, BUREO, Encarna, VERNAL, Maria-Teresa, GONZALEZ, Marcos, VIDRIALES, Belén, BRUNET, Salut, ESTEVE, Jordi, DEL POTRO, Eloy, RIVAS, Concepción, MORENO, Maria-José, TORMO, Mar

“…Imatinib, given concurrently or alternating with chemotherapy, has improved the response and survival of patients with Philadelphia chromosome-positive acute…”
Get full text

Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings by Urbano-Ispizua, Alvaro, Rozman, Ciril, Pimentel, Pedro, Solano, Carlos, de la Rubia, Javier, Brunet, Salut, Pérez-Oteyza, Jaime, Ferrá, Christelle, Zuazu, Javier, Caballero, Dolores, Bargay, Joan, Carvalhais, Alzira, Dı́ez, Jose Luis, Espigado, Ildefonso, Alegre, Adrián, Rovira, Montserrat, Campilho, Fernando, Odriozola, Jesús, Sanz, Miguel Angel, Sierra, Jordi, Garcı́a-Conde, Javier, Montserrat, Emili

“…A study on 315 patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings was performed to determine risk factors for…”
Get full text

Analysis of economic and social costs of adverse events associated with blood transfusions in Spain by Ribed-Sánchez, Borja, González-Gaya, Cristina, Varea-Díaz, Sara, Corbacho-Fabregat, Carlos, Bule-Farto, Isabel, Pérez de-Oteyza, Jaime

“…To calculate, for the first time, the direct and social costs of transfusion-related adverse events in order to include them in the National Healthcare…”
Get full text

Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non‐Hodgkin B‐cell lymphomas by Sancho, Juan‐Manuel, Navarro, Belén, Soler Campos, Joan Alfons, Oteyza, Jaime Pérez, Barrenetxea Lekue, Cristina, Bregni, Marco, Grasso Cicala, Silvina, Spione, Mario, Mombiedro, Cristina, Soler, Begoña, Zinzani, Pier Luigi

“…Background and objective Few treatment options exist for patients with relapsed/refractory (R/R) B‐cell non‐Hodgkin lymphoma (NHL) who fail first‐ and…”
Get full text

A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients by Martínez-Cuadrón, David, Gil, Cristina, Serrano, Josefina, Rodríguez, Gabriela, Pérez-Oteyza, Jaime, García-Boyero, Raimundo, Jiménez-Bravo, Santiago, Vives, Susana, Vidriales, María Belén, Lavilla, Esperanza, Pérez-Simón, José A., Tormo, Mar, Colorado, Mercedes, Bergua, Juan, López, Juan A., Herrera, Pilar, Hernández-Campo, Pilar, Gorrochategui, Julián, Primo, Daniel, Rojas, Jose Luis, Villoria, Jesús, Moscardó, Federico, Troconiz, Iñaki, Linares Gómez, María, Martínez-López, Joaquín, Ballesteros, Joan, Sanz, Miguel, Montesinos, Pau

“…•Ex vivo test predicts the response to first line CYT and IDA induction chemotherapy.•The use of whole bone marrow samples could lead to more reliable…”
Get full text

Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations by Adema, Vera, Larráyoz, María J., Calasanz, María J., Palomo, Laura, Patiño‐García, Ana, Agirre, Xabier, Hernández‐Rivas, Jesús M., Lumbreras, Eva, Buño, Ismael, Martinez‐Laperche, Carolina, Mallo, Mar, García, Olga, Álvarez, Sara, Blazquez, Beatriz, Cervera, José, Luño, Elisa, Valiente, Alberto, Vallespí, María T., Arenillas, Leonor, Collado, Rosa, Pérez‐Oteyza, Jaime, Solé, Francesc

Get full text

Recommendations on the use of azole antifungals in hematology-oncology patients by Azanza, J R, Mensa, J, Barberán, J, Vázquez, L, Pérez de Oteyza, J, Kwon, M, Yáñez, L, Aguado, J M, Cubillo Gracian, A, Solano, C, Ruiz Camps, I, Fortún, J, Salavert Lletí, M, Gudiol, C, Olave Rubio, T, García-Vidal, C, Rovira Tarrats, M, Suárez-Lledó Grande, M, González-Sierra, P, Dueñas Gutiérrez, C

“…The administration of antifungals for therapeutic and, especially, prophylactic purposes is virtually a constant in patients requiring hematology-oncology…”
Get full text

Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM by Mateos, María-Victoria, Martínez-López, Joaquín, Hernández, Miguel-Teodoro, Ocio, Enrique-M., Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C., Martín Ramos, María-Luisa, Oriol, Albert, Bargay, Joan, Bengoechea, Enrique, González, Yolanda, Pérez de Oteyza, Jaime, Gironella, Mercedes, Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Paiva, Bruno, Cedena, María-Teresa, Puig, Noemí, Bladé, Joan, Lahuerta, Juan-José, San-Miguel, Jesús

“…Bortezomib plus melphalan and prednisone (VMP) and lenalidomide plus low-dose dexamethasone (Rd) are 2 standards of care for elderly untreated multiple myeloma…”
Get full text

Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role by Rodríguez-Otero, Paula, Mateos, María Victoria, Martínez-López, Joaquín, Martín-Calvo, Nerea, Hernández, Miguel-Teodoro, Ocio, Enrique M., Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C., Bargay, Joan, Bengoechea, Enrique, González, Yolanda, de Oteyza, Jaime Pérez, Gironella, Mercedes, Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Palomera, Luis, de Arriba, Felipe, Cedena, María Teresa, Paiva, Bruno, Puig, Noemí, Oriol, Albert, Bladé, Joan, Lahuerta, Juan José, San Miguel, Jesús F.

“…Although survival of elderly myeloma patients has significantly improved there is still a subset of patients who, despite being fit and achieving optimal…”
Get full text

Pharmacological Profiles of Acute Myeloid Leukemia Treatments in Patient Samples by Automated Flow Cytometry: A Bridge to Individualized Medicine by Bennett, Teresa A, Montesinos, Pau, Moscardo, Federico, Martinez-Cuadron, David, Martinez, Joaquin, Sierra, Jorge, García, Raimundo, de Oteyza, Jaime Perez, Fernandez, Pascual, Serrano, Josefina, Fernandez, Angeles, Herrera, Pilar, Gonzalez, Ataulfo, Bethancourt, Concepcion, Rodriguez-Macias, Gabriela, Alonso, Arancha, Vera, Juan A, Navas, Begoña, Lavilla, Esperanza, Lopez, Juan A, Jimenez, Santiago, Simiele, Adriana, Vidriales, Belen, Gonzalez, Bernardo J, Burgaleta, Carmen, Hernandez Rivas, Jose A, Mascuñano, Raul Cordoba, Bautista, Guiomar, Perez Simon, Jose A, Fuente, Adolfo de la, Rayón, Consolación, Troconiz, Iñaki F, Janda, Alvaro, Bosanquet, Andrew G, Hernandez-Campo, Pilar, Primo, Daniel, Lopez, Rocio, Liebana, Belen, Rojas, Jose L, Gorrochategui, Julian, Sanz, Miguel A, Ballesteros, Joan

“…Micro-Abstract We have estimated the pharmacological sensitivity and synergism of 125 individual patient samples for all drugs and combination treatments for…”
Get full text

Economic Analysis of the Reduction of Blood Transfusions during Surgical Procedures While Continuous Hemoglobin Monitoring Is Used by Ribed-Sánchez, Borja, González-Gaya, Cristina, Varea-Díaz, Sara, Corbacho-Fabregat, Carlos, Pérez-Oteyza, Jaime, Belda-Iniesta, Cristóbal

“…Two million transfusions are performed in Spain every year. These come at a high economic price for the health system, increasing the morbidity and mortality…”
Get full text

Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia by Megías-Vericat, Juan Eduardo, Martínez-Cuadrón, David, López, Joaquín Martínez, Bergua, Juan Miguel, Tormo, Mar, Serrano, Josefina, González, Ataulfo, de Oteyza, Jaime Pérez, Vives, Susana, Vidriales, Belén, Herrera, Pilar, Vera, Juan Antonio, Martínez, Aurelio López, de la Fuente, Adolfo, Amador, Ma Lourdes, Hernández-Rivas, José-Ángel, Fernández, Ma Ángeles, Cerveró, Carlos Javier, Morillo, Daniel, Campo, Pilar Hernández, Gorrochategui, Julián, Primo, Daniel, Rojas, José Luis, Guenova, Margarita, Ballesteros, Joan, Sanz, Miguel, Montesinos, Pau

“…Induction schedules in acute myeloid leukemia (AML) are based on combinations of cytarabine and anthracyclines. The choice of the anthracycline employed has…”
Get full text

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma by Gordon, Leo I, Kaplan, Jason B, Popat, Rakesh, Burris, 3rd, Howard A, Ferrari, Silvia, Madan, Sumit, Patel, Manish R, Gritti, Giuseppe, El-Sharkawi, Dima, Chau, Ian, Radford, John A, Pérez de Oteyza, Jaime, Zinzani, Pier Luigi, Iyer, Swaminathan, Townsend, William, Karmali, Reem, Miao, Harry, Proscurshim, Igor, Wang, Shining, Wu, Yujun, Stumpo, Kate, Shou, Yaping, Carpio, Cecilia, Bosch, Francesc

“…TAK-659 is an investigational, dual SYK/FLT3 inhibitor with preclinical activity in B-cell malignancy models. This first-in-human, dose-escalation/expansion…”
Get full text

Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role by Rodríguez-Otero, Paula, Mateos, María Victoria, Martínez-López, Joaquín, Martín-Calvo, Nerea, Hernández, Miguel-Teodoro, Ocio, Enrique M., Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C., Bargay, Joan, Bengoechea, Enrique, González, Yolanda, de Oteyza, Jaime Pérez, Gironella, Mercedes, Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Palomera, Luis, de Arriba, Felipe, Cedena, María Teresa, Paiva, Bruno, Puig, Noemí, Oriol, Albert, Bladé, Joan, Lahuerta, Juan José, Miguel, Jesús F. San

“…Following the publication of this article, the author notes that the following information was missed from the acknowledgments section:…”
Get full text

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study by García-Suárez, Julio, de la Cruz, Javier, Cedillo, Ángel, Llamas, Pilar, Duarte, Rafael, Jiménez-Yuste, Víctor, Hernández-Rivas, José Ángel, Gil-Manso, Rodrigo, Kwon, Mi, Sánchez-Godoy, Pedro, Martínez-Barranco, Pilar, Colás-Lahuerta, Blanca, Herrera, Pilar, Benito-Parra, Laurentino, Alegre, Adrián, Velasco, Alberto, Matilla, Arturo, Aláez-Usón, María Concepción, Martos-Martínez, Rafael, Martínez-Chamorro, Carmen, Susana-Quiroz, Keina, Del Campo, Juan Francisco, de la Fuente, Adolfo, Herráez, Regina, Pascual, Adriana, Gómez, Elvira, Pérez-Oteyza, Jaime, Ruiz, Elena, Alonso, Arancha, González-Medina, José, Martín-Buitrago, Lucía Núñez, Canales, Miguel, González-Gascón, Isabel, Vicente-Ayuso, María Carmen, Valenciano, Susana, Roa, María García, Monteliu, Pablo Estival, López-Jiménez, Javier, Escobar, Cristián Escolano, Ortiz-Martín, Javier, Diez-Martin, José Luis, Martinez-Lopez, Joaquín, Serí-Merino, Cristina, Queiroz-Cervantes, Keina, Fernandez, Mónica Estévez, Peñalva-Moreno, María-José, Naya-Errea, Daniel, Bermejo-Martínez, Laura, Llorente-González, Laura

“…Abstract Background Patients with cancer have been shown to have a higher risk of clinical severity and mortality compared to non-cancer patients with…”
Get full text